TECTA: use of proton pump inhibitors can increase the risk of COVID-19 infection
Updated November 2020. A recent study pre-published by the American Journal of Gastroenterology has identified a connection between the use of Proton Pump Inhibitors (PPIs) and the risk of COVID-19 infections. The risk of contracting the infection appears to increase with the PPI dose. Here we describe how a...